Decreased CD8 cell-mediated viral suppression and other immunologic characteristics of women who transmit human immunodeficiency virus to their infants

Journal of Infectious Diseases

Volumn 179, Issue 6, 1999, Pages 1388-1394

  Plaeger, Susan ^a   Bermudez, Saul ^a   Mikyas, Yeshi ^a   Harawa, Nina ^a   Dickover, Ruth ^a   Mark, Dustin ^a   Dillon, Maryanne ^a   Bryson, Yvonne J ^a   Boyer, Pamela J ^a   Sinsheimer, Janet S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; ZIDOVUDINE;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION RISK; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; VERTICAL TRANSMISSION; VIRUS IMMUNITY; VIRUS TRANSMISSION;

ANTIGENS, CD3; ANTIGENS, CD4; BETA 2-MICROGLOBULIN; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV CORE PROTEIN P24; HIV SEROPOSITIVITY; HUMANS; NEOPTERIN; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RNA, VIRAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033060853     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314746     Document Type: Article

References (22)

1. 1. Peckham C, Gibb D. Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 1995;333:298-302.
2. 2. Dickover RE, Garratty EM, Herman SA, et al. Identification of levels of maternal HIV-I RNA associated with risk of perinatal transmission: Effect of maternal zidovudine treatment on viral load. JAMA 1996;275:599-605.
3. 3. Borkowsky W, Krasinski K, Cao Y, et al. Correlation of perinatal transmission of HIV-I with maternal viremia and lymphocyte phenotypes. J Pediatr 1994;125:345-51.
4. 4. Mayaux MJ, Dussaix E, Isopet J, et al. Maternal virus load during pregnancy and mother-to-child transmission of HIV-I: the French perinatal cohort studies. SEROGEST Cohort Group. J Infect Dis 1997;175:172-5.
5. 5. Coll O, Hernandez M, Boucher CA, et al. Vertical HIV-I transmission correlates with high maternal viral load at delivery. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:26-30.
6. 6. Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996;271:324-8.
7. 7. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-34.
8. 8. Levy JA, Mackewicz CE, Barker E. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 1996;17:217-24.
9. 9. Ferbas J, Kaplan AH, Hausner MA, et al. Virus burden in long-term survivors of HIV infection is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis 1995;172:329-39.
10. 10. Fahey JL, Mitsuyasu R. Immunomodulatory approaches to the therapy of AIDS. Clin Immunother 1996;6:39-53.
11. 11. Pantaleo G, Graziosi C, Fauci AS. Virologic and immunologic events in primary HIV infection. Springer Semin Immunopathol 1997;18:257-66.
12. 12. Plaeger-Marshall S., Isacescu V, O'Rourke S, Bertolli J, Bryson YJ, Stiehm ER. T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping. Clin Immunol Immunopathol 1994;71:19-26.
13. 13. Hausner MA, Giorgi JV, Plaeger-Marshall S. A reproducible method to detect CD8 T cell mediated inhibition of HIV production from naturally infected CD4 cells. J Immunol Methods 1993;157:181-7.
14. 14. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
15. 15. Mikyas Y, Aziz N, Harawa N, et al. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J Reprod Immunol 1997;33:157-170.
16. 16. Ferbas J, Detels R, Giorgi JV. CD8 cell modulation of HIV replication in autologous CD4 cells from HIV-infected non-progressors. Presented at the 1997 UCLA/UCT Palm Springs Symposium on HIV/AIDS, 13 16 March, 1997.
17. 17. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
18. 18. Boyer PJJ, Dillon M, Navaie M, et al. Factors predictive of maternal-fetal transmission of HIV-I: a protective role for zidovudine (ZDV) given during pregnancy and/or delivery. JAMA 1994;271:1925-30.
19. 19. Pitt J, Brambilla D, Reichelderfer P, et al. Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the Women and Infants Transmission Study. J Infect Dis 1997;175:567-75.
20. 20. Moodley D, Coovadia HM, Bobat RA. Beta 2-microglobulin and CD4/CD8 ratio as HIV-I markers of maternal transmissibility, neonatal infection and disease progression. Ann Trop Paediatr 1996;16:155-60.
21. 21. Rudin C, Camli C, Schnuriger H, Biedermann K, Lauper U, Kind C. HIV and pregnancy. Schweiz Med Wochenschr 1995;125:2322-9.
22. 22. Salazar-Gonzalez JF, Martinez-Maza O, Aziz N, et al. Relationship of plasma HIV-RNA levels and levels of TNF-α and immune activation products in HIV infection. Clin Immunol Immunopathol 1997;84:36-45.